Bg pattern

AZITHROMYCIN TARBIS 250 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG

Prescription review online

Prescription review online

A doctor will review your case and decide whether a prescription is medically appropriate.

Talk to a doctor about this medicine

Talk to a doctor about this medicine

Discuss your symptoms and possible next steps in a quick online consultation.

This page is for general information. Consult a doctor for personal advice. Call emergency services if symptoms are severe.
About the medicine

How to use AZITHROMYCIN TARBIS 250 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG

Translated with AI

This page provides general information and does not replace a doctor’s consultation. Always consult a doctor before taking any medication. Seek urgent medical care if symptoms are severe.

Show original

Introduction

Package Leaflet: Information for the User

Azitromicina Tarbis 250 mg Powder for Oral Suspension in Sachet EFG

Azitromicina (Dihydrate)

Read this package leaflet carefully before you start taking this medicine because it contains important information for you.

  • Keep this package leaflet, you may need to read it again.
  • If you have any further questions, ask your doctor or pharmacist.
  • This medicine has been prescribed for you only. Do not pass it on to others. It may harm them, even if their symptoms are the same as yours.
  • If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet. See section 4.

Contents of the Package Leaflet

  1. What Azitromicina Tarbis 250 mg is and what it is used for
  2. What you need to know before you take Azitromicina Tarbis 250 mg
  3. How to take Azitromicina Tarbis 250 mg
  4. Possible side effects
  5. Storage of Azitromicina Tarbis 250 mg
  6. Contents of the pack and further information

1. What Azitromicina Tarbis 250 mg is and what it is used for

Azitromicina belongs to a group of antibiotics called macrolide antibiotics.

Antibiotics are used to treat bacterial infections and are not effective against viral infections such as the flu or the common cold.

It is important that you follow the instructions regarding the dose, administration interval, and treatment duration indicated by your doctor.

Do not store or reuse this medicine. If you have any leftover antibiotic after completing the treatment, return it to the pharmacy for proper disposal. Do not throw away medicines via wastewater or household waste.

It is used to treat the following infections:

  • Infections of the upper and lower respiratory tract, such as otitis media, sinusitis, pharyngitis, bronchitis, and pneumonia.
  • Infections of the skin and soft tissues.
  • Sexually transmitted diseases.
Doctor consultation

Not sure if this medicine is right for you?

Discuss your symptoms and treatment with a doctor online.

2. What you need to know before you take Azitromicina Tarbis 250 mg

Do not take Azitromicina Tarbis:

  • if you are allergic (hypersensitive) to azitromicina, to another macrolide antibiotic, or to any of the other components of this medicine (listed in section 6).

Warnings and precautions

Consult your doctor or pharmacist before taking Azitromicina Tarbis:

  • If you have a severe liver disease. In this case, inform your doctor.
  • If during treatment with this medicine or after completing it, you experience diarrhea, inform your doctor.
  • It is possible that, as with other antibiotics, during treatment with this medicine, a fungal overinfection may occur. If this happens, inform your doctor.
  • If during treatment with Azitromicina Tarbis you experience an allergic reaction, characterized by symptoms such as itching, redness, skin rash, swelling, or difficulty breathing. If this happens, inform your doctor immediately.

Children

Azitromicina Tarbis should not be administered to children under 6 months.

Using Azitromicina Tarbis with other medicines

Tell your doctor or pharmacist if you are taking, have recently taken, or might take any other medicines.

Azitromicina may interact with other medicines. Tell your doctor or pharmacist if you are taking any of the following medicines:

  • Ergot derivatives (such as ergotamine, used to treat migraines).
  • Ciclosporin (a medicine used in transplant patients).
  • Digoxin (a medicine used to treat heart arrhythmias).
  • Colchicine (used for gout and familial Mediterranean fever)
  • Antacids, cimetidine (medicines used for digestive problems). If you are taking antacids and Azitromicina Tarbis, it is recommended to avoid taking both medicines at the same time of day.
  • Oral anticoagulants (medicines used to prevent blood clots).
  • Nelfinavir, zidovudine (medicines for the treatment of infections caused by the human immunodeficiency virus).
  • Terfenadine (a medicine used to treat allergies and hay fever).
  • Rifabutin (a medicine for the treatment of pulmonary tuberculosis and non-pulmonary infections caused by mycobacteria).

Pregnancy and breastfeeding

If you are pregnant or breastfeeding, think you may be pregnant, or are planning to have a baby, ask your doctor or pharmacist for advice before taking this medicine.

Azitromicina Tarbis should not be used during pregnancy and breastfeeding unless, in the doctor's opinion, the benefit to the mother outweighs the risk to the baby.

Driving and using machines

There is no evidence that Azitromicina Tarbis affects the ability to drive or use machines.

Azitromicina Tarbis contains sucrose

This medicine contains sucrose. If your doctor has told you that you have an intolerance to some sugars, consult them before taking this medicine.

Patients with diabetes mellitus should note that this medicine contains 3.6 g of sucrose per 5 ml of reconstituted suspension.

Medicine questions

Started taking the medicine and have questions?

Discuss your symptoms and treatment with a doctor online.

3. How to take Azitromicina Tarbis 250 mg

Follow exactly the administration instructions of this medicine given by your doctor. If you are unsure, consult your doctor or pharmacist again.

Remember to take your medicine.

Your doctor will tell you the duration of treatment with Azitromicina Tarbis. Do not stop treatment before it is completed, as there is a risk of relapse of the disease.

Azitromicina Tarbis is administered orally. Pour the contents of the sachet into a glass, add a little water, and mix well. The resulting suspension should be taken immediately.

The dose will be determined by your doctor based on your individual needs and the type of infection.

To achieve optimal efficacy, follow your doctor's instructions regarding the dose and treatment duration.

The recommended dose and administration frequency are:

Adults (including elderly patients): 500 mg (2 sachets in a single dose) once a day for 3 consecutive days, with a total dose of 1500 mg (6 sachets). Alternatively, the same total dose can be administered over 5 days, with a dose of 500 mg (2 sachets) on the first day, followed by 250 mg (1 sachet) daily from day 2 to 5.

For the treatment of sexually transmitted diseases, the dose is 1000 mg (4 sachets) taken as a single oral dose.

Children and adolescents: The dose of 250 mg of this presentation is only suitable for children and adolescents over 45 kg in weight, for whom the same dose as for adults is recommended.

For those with a lower weight, it is recommended to use other presentations.

If you think the effect of Azitromicina Tarbis is too strong or too weak, talk to your doctor or pharmacist.

If you take more Azitromicina Tarbis than you should

Consult your doctor or pharmacist immediately.

In case of overdose or accidental ingestion, consult your doctor or pharmacist immediately or call the Toxicology Information Service, phone: 91 562 04 20, indicating the medicine and the amount taken.

If you forget to take Azitromicina Tarbis

Do not take a double dose to make up for forgotten doses.

If you have any further questions on the use of this medicine, ask your doctor or pharmacist.

4. Possible side effects

Like all medicines, this medicine can cause side effects, although not everybody gets them.

Most side effects observed in clinical trials were mild to moderate, reversible after discontinuation of the drug, and mainly affected the digestive system, consisting mainly of nausea, vomiting, diarrhea, or abdominal pain. Potentially serious side effects such as laryngeal edema (due to an allergic reaction) or liver function alterations accompanied by yellowing of the skin occurred rarely.

In addition, during treatment with Azitromicina Tarbis, any of the following side effects may appear, described for azitromicina when administered orally.

  • Thrombocytopenia (decrease in platelet count) and transient episodes of mild neutropenia (decrease in white blood cell count).
  • Aggression, nervousness, agitation, anxiety, dizziness/vertigo, convulsions, headache, somnolence, and hyperactivity.
  • Hearing and, exceptionally, taste disorders.
  • Cardiac disorders.
  • Digestive disorders such as anorexia, nausea, vomiting/diarrhea (which can exceptionally cause dehydration), soft stools, abdominal discomfort (pain/cramps), constipation, gas, severe diarrhea, and rarely, tongue discoloration.
  • Liver and kidney function alterations (rarely severe).
  • Skin reactions such as itching, rash, photosensitivity, fluid accumulation, or urticaria (hives). Exceptionally, serious skin reactions have occurred. Rare: cutaneous eruption characterized by the rapid appearance of red skin areas dotted with small pustules (small blisters filled with white/yellow liquid).
  • Joint pain.
  • Vaginal fungal infection (vaginitis).
  • Fungal infections, fatigue, tingling sensation, and allergic reactions.

Reporting of side effects

If you experience any side effects, talk to your doctor or pharmacist. This includes any possible side effects not listed in this package leaflet. You can also report side effects directly through the Spanish Pharmacovigilance System for Human Use Medicines: https://www.notificaram.es. By reporting side effects, you can help provide more information on the safety of this medicine.

5. Storage of Azitromicina Tarbis 250 mg

Keep this medicine out of the sight and reach of children.

Do not use this medicine after the expiry date which is stated on the sachet and the carton after EXP. The expiry date is the last day of the month stated.

Medicines should not be disposed of via wastewater or household waste. Take the empty pack and any remaining medicine to a pharmacy for proper disposal. If you are unsure, ask your pharmacist how to dispose of the pack and any remaining medicine. This will help protect the environment.

6. Contents of the pack and further information

Composition of Azitromicina Tarbis 250 mg

  • The active substance is azitromicina. Each sachet contains 250 mg of azitromicina (dihydrate).
  • The other components (excipients) are: sucrose, hydroxypropylcellulose (E-463), anhydrous trisodium phosphate, xanthan gum (E-415), cherry flavor, vanilla flavor, and banana flavor.

Appearance of the product and contents of the pack

Azitromicina Tarbis 250 mg is a powder for oral suspension in sachet.

Each pack contains 3 sachets.

Marketing authorization holder and manufacturer

Marketing authorization holder:

TARBIS FARMA, S.L.

Gran Vía Carlos III, 94

08028-BARCELONA (Spain)

Manufacturer:

KERN PHARMA, S.L.

Polígono Ind. Colón II

Venus, 72

08228 Terrassa (Barcelona)

Date of last revision of this package leaflet: May 2018

Detailed and updated information on this medicine is available on the website of the Spanish Agency for Medicines and Health Products (AEMPS) http://www.aemps.gob.es/

Online doctors for AZITHROMYCIN TARBIS 250 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG

Discuss questions about AZITHROMYCIN TARBIS 250 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG, including use, safety considerations and prescription review, subject to medical assessment and local regulations.

5.0 (69)
Doctor

Tarek Agami

General medicine 11 years exp.

Dr. Tarek Agami is a general practitioner registered in both Portugal and Israel, with broad experience in family and preventive medicine. He offers online consultations for adults and children, providing personalised support for primary care needs, chronic disease management, and everyday health concerns.

Dr. Agami received clinical training and worked in leading medical institutions in Israel (Kaplan Medical Center, Barzilai Medical Center, Wolfson Medical Center) and Portugal (European Healthcare City, Viscura Internacional, Hospital Dr. José Maria Grande, Hospital Vila Franca de Xira). His approach combines international medical standards with individualised attention to each patient.

Main areas of consultation:

  • Diagnosis and treatment of acute and chronic conditions (high blood pressure, diabetes, respiratory infections, cardiovascular symptoms)
  • Evaluation of symptoms and guidance on further diagnostic testing
  • Preventive check-ups and regular health monitoring
  • Medical support during travel or after relocation
  • Treatment adjustments and lifestyle recommendations based on your personal history
Dr. Agami provides medical support for patients using GLP-1 medications (such as Ozempic or Mounjaro) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Portugal and Israel.

Dr. Agami is committed to evidence-based, patient-centred care, ensuring that each person receives trusted medical support tailored to their health goals.

Camera Book a video appointment
€69
5.0 (63)
Doctor

Nuno Tavares Lopes

Family medicine 18 years exp.

Dr. Nuno Tavares Lopes is a licensed physician in Portugal with 17 years of experience in emergency medicine, family and general practice, and public health. He is the Director of Medical and Public Health Services at an international healthcare network and serves as an external consultant for the WHO and ECDC.

  • Emergency care: infections, fever, chest/abdominal pain, minor injuries, paediatric emergencies
  • Family medicine: hypertension, diabetes, cholesterol, chronic disease management
  • Travel medicine: pre-travel advice, vaccinations, fit-to-fly certificates, travel-related illnesses
  • Sexual and reproductive health: PrEP, STD prevention, counselling, treatment
  • Weight management and wellness: personalised weight loss programmes, lifestyle guidance
  • Skin and ENT issues: acne, eczema, allergies, rashes, sore throat, sinusitis
  • Pain management: acute and chronic pain, post-surgical care
  • Public health: prevention, health screenings, long-term monitoring
  • Sick leave (Baixa médica) connected to Segurança Social in Portugal
  • IMT medical certificates for driving licence exchange
Dr. Nuno Tavares Lopes provides medical support for patients using GLP-1 medications (Mounjaro, Wegovy, Ozempic, Rybelsus) as part of a weight loss strategy. He offers individualised treatment planning, regular follow-up, dose adjustment, and advice on combining medication with sustainable lifestyle changes. Consultations follow the medical standards accepted in Europe.

Dr. Lopes also provides interpretation of medical tests, follow-up care for complex patients, and multilingual support. Whether for urgent concerns or long-term care, he helps patients act with clarity and confidence.

Camera Book a video appointment
€59
5.0 (17)
Doctor

Anastasiia Shalko

Family medicine 13 years exp.

Dr. Anastasiia Shalko is a general practitioner with a background in both paediatrics and general medicine. She graduated from Bogomolets National Medical University in Kyiv and completed her paediatric internship at the P.L. Shupyk National Medical Academy of Postgraduate Education. After working as a paediatrician in Kyiv, she relocated to Spain, where she has been practising general medicine since 2015, providing care for both adults and children.

Her work focuses on urgent, short-term medical concerns – situations where patients need quick guidance, symptom assessment and clear next steps. She helps people understand whether their symptoms require in-person evaluation, home management or a change in treatment. Common reasons for booking an online consultation include:

  • acute respiratory symptoms (cough, sore throat, runny nose, fever)
  • viral illnesses such as colds and seasonal infections
  • gastrointestinal complaints (nausea, diarrhoea, abdominal pain, gastroenteritis)
  • sudden changes in how a child or adult feels
  • questions about existing treatment and whether adjustments are needed
  • renewal of prescriptions when clinically appropriate
Dr. Shalko works specifically with urgent and short-term problems, providing practical recommendations and helping patients determine the safest next step. She explains symptoms clearly, guides patients through decision-making and offers straightforward medical advice for everyday acute issues.

She does not provide long-term management of chronic conditions, ongoing follow-up or comprehensive care plans for complex long-term illnesses. Her consultations are designed for acute symptoms, sudden concerns and situations where timely medical input is important.

With clinical experience in both paediatrics and general medicine, Dr. Shalko confidently supports adults and children. Her communication style is clear, simple and reassuring, helping patients feel informed and supported throughout the consultation.

Camera Book a video appointment
€50
5.0 (3)
Doctor

Tomasz Grzelewski

Dermatology 21 years exp.

Dr Tomasz Grzelewski is an MD, PhD specialist in allergy, paediatrics, general practice and sports medicine, with a clinical focus on dermatology, endocrinology, allergology and sports-related health. He has more than 20 years of clinical experience and completed his medical training at the Medical University of Łódź, where he defended his PhD thesis with distinction. His doctoral research was recognised by the Polish Society of Allergology for its innovative contribution to the field. Throughout his career, he has gained extensive expertise in diagnosing and managing a wide range of allergic and paediatric conditions, including modern allergen desensitisation techniques.

For five years, Dr Grzelewski served as the Head of two paediatric departments in Poland, managing complex clinical cases and leading multidisciplinary teams. He also worked in medical centres in the United Kingdom, gaining experience across both primary care and specialist environments. With over a decade of telemedicine experience, he has provided online consultations across Europe and is valued for his clear, structured and evidence-based medical guidance.

Dr Grzelewski is actively involved in clinical programmes focused on modern anti-allergic therapies. As a Principal Investigator, he leads research projects on sublingual and oral allergen desensitisation, supporting evidence-based progress in allergy treatment for both children and adults.

In addition to his background in allergology and paediatrics, he completed dermatology studies through the Cambridge Education Group (Royal College of Physicians of Ireland) and a Clinical Endocrinology course at Harvard Medical School. This advanced training enhances his ability to manage skin manifestations of allergies, atopic conditions, urticaria, endocrine-related symptoms and complex immunological reactions.

Patients commonly seek his care for:

  • seasonal and perennial allergies
  • allergic rhinitis and chronic nasal symptoms
  • asthma and breathing difficulties
  • food and medication allergies
  • urticaria, atopic dermatitis and skin reactions
  • recurrent infections in children
  • sports-related health questions
  • general family medicine concerns
Dr Tomasz Grzelewski is known for his clear communication style, structured medical approach and ability to explain treatment options in a concise and accessible way. His multidisciplinary background across allergy, paediatrics, dermatology and endocrinology allows him to provide safe, up-to-date and comprehensive care for patients of all ages.
Camera Book a video appointment
€80

Frequently Asked Questions

Is a prescription required for AZITHROMYCIN TARBIS 250 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG?
AZITHROMYCIN TARBIS 250 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG requires a prescription in Spain. You can check with a doctor online whether this medicine may be appropriate for your situation.
What is the active substance in AZITHROMYCIN TARBIS 250 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG?
The active ingredient in AZITHROMYCIN TARBIS 250 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG is azithromycin. This information helps identify medicines with the same composition but different brand names.
Who manufactures AZITHROMYCIN TARBIS 250 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG?
AZITHROMYCIN TARBIS 250 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG is manufactured by Tarbis Farma S.L.. Pharmacy brands and packaging may differ depending on the distributor.
Which doctors can assess the use of AZITHROMYCIN TARBIS 250 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG online?
Doctors such as Family doctors, Psychiatrists, Dermatologists, Cardiologists, Endocrinologists, Gastroenterologists, Pulmonologists, Nephrologists, Rheumatologists, Hematologists, Infectious disease physicians, Allergists, Geriatricians, Paediatricians, Oncologists may assess whether AZITHROMYCIN TARBIS 250 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG is appropriate, depending on your situation and local regulations. You can book an online consultation to discuss your symptoms and possible next steps.
What are the alternatives to AZITHROMYCIN TARBIS 250 mg ORAL SUSPENSION POWDER FOR SOLUTION EFG?
Other medicines with the same active substance (azithromycin) include ARATRO 200 mg/5 ml POWDER FOR ORAL SUSPENSION IN A BOTTLE, ARATRO 500 mg FILM-COATED TABLETS, ARATRO 500 mg ORAL SUSPENSION POWDER IN SACHET. These may have different brand names or formulations but contain the same therapeutic ingredient. Always consult a doctor before switching or starting a new medicine.
bg-pattern-dark

Stay informed about Oladoctor

News about new services, product updates and useful information for patients.

Follow us on social media